1. Home
  2. AMZE vs CARM Comparison

AMZE vs CARM Comparison

Compare AMZE & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMZE
  • CARM
  • Stock Information
  • Founded
  • AMZE 2019
  • CARM 2016
  • Country
  • AMZE United States
  • CARM United States
  • Employees
  • AMZE N/A
  • CARM N/A
  • Industry
  • AMZE Beverages (Production/Distribution)
  • CARM Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMZE Consumer Staples
  • CARM Health Care
  • Exchange
  • AMZE Nasdaq
  • CARM Nasdaq
  • Market Cap
  • AMZE 16.1M
  • CARM 16.4M
  • IPO Year
  • AMZE 2021
  • CARM N/A
  • Fundamental
  • Price
  • AMZE $3.41
  • CARM $0.29
  • Analyst Decision
  • AMZE
  • CARM Hold
  • Analyst Count
  • AMZE 0
  • CARM 5
  • Target Price
  • AMZE N/A
  • CARM $0.90
  • AVG Volume (30 Days)
  • AMZE 125.5K
  • CARM 381.2K
  • Earning Date
  • AMZE 08-14-2025
  • CARM 08-22-2025
  • Dividend Yield
  • AMZE N/A
  • CARM N/A
  • EPS Growth
  • AMZE N/A
  • CARM N/A
  • EPS
  • AMZE N/A
  • CARM N/A
  • Revenue
  • AMZE $1,054,111.00
  • CARM $10,767,000.00
  • Revenue This Year
  • AMZE N/A
  • CARM N/A
  • Revenue Next Year
  • AMZE N/A
  • CARM N/A
  • P/E Ratio
  • AMZE N/A
  • CARM N/A
  • Revenue Growth
  • AMZE N/A
  • CARM N/A
  • 52 Week Low
  • AMZE $2.72
  • CARM $0.14
  • 52 Week High
  • AMZE $28.72
  • CARM $1.27
  • Technical
  • Relative Strength Index (RSI)
  • AMZE N/A
  • CARM 40.00
  • Support Level
  • AMZE N/A
  • CARM $0.28
  • Resistance Level
  • AMZE N/A
  • CARM $0.30
  • Average True Range (ATR)
  • AMZE 0.00
  • CARM 0.02
  • MACD
  • AMZE 0.00
  • CARM -0.00
  • Stochastic Oscillator
  • AMZE 0.00
  • CARM 30.77

About AMZE Amaze Holdings Inc. Common Stock

Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

Share on Social Networks: